Total Valuation
Mesoblast Limited has a market cap or net worth of $2.23B. The enterprise value is $3.52K.
Market Cap$2.23B
Enterprise Value$3.52K
Share Statistics
Mesoblast Limited has 1,298,748,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,298,748,200
Owned by Insiders29.31%
Owned by Institutions0.01%
Financial Efficiency
Mesoblast Limited’s return on equity (ROE) is -0.10 and return on invested capital (ROIC) is -7.43%.
Return on Equity (ROE)-0.10
Return on Assets (ROA)-0.08
Return on Invested Capital (ROIC)-7.43%
Return on Capital Employed (ROCE)-0.08
Revenue Per Employee1.14M
Profits Per Employee0.00
Employee Count108
Asset Turnover0.16
Inventory Turnover0.70
Valuation Ratios
The current PE Ratio of Mesoblast Limited is ―. Mesoblast Limited’s PEG ratio is 0.61.
PE Ratio―
PS Ratio14.29
PB Ratio3.09
Price to Fair Value3.09
Price to FCF-39.26
Price to Operating Cash Flow-40.60
PEG Ratio0.61
Income Statement
In the last 12 months, Mesoblast Limited had revenue of 122.89M and earned -58.76M in profits. Earnings per share was -0.05.
Revenue122.89M
Gross Profit103.34M
Operating Income-52.40M
Pretax Income-58.14M
Net Income-58.76M
EBITDA-43.62M
Earnings Per Share (EPS)-0.05
Cash Flow
In the last 12 months, operating cash flow was -59.76M and capital expenditures -1.11M, giving a free cash flow of -60.87M billion.
Operating Cash Flow-59.76M
Free Cash Flow-60.87M
Free Cash Flow per Share-0.05
Dividends & Yields
Mesoblast Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.25
52-Week Price Change25.83%
50-Day Moving Average1.73
200-Day Moving Average1.63
Relative Strength Index (RSI)62.18
Average Volume (3m)33.39K
Important Dates
Mesoblast Limited upcoming earnings date is Mar 4, 2027, TBA (Confirmed).
Last Earnings DateFeb 27, 2026
Next Earnings DateMar 4, 2027
Ex-Dividend Date―
Financial Position
Mesoblast Limited as a current ratio of 2.43, with Debt / Equity ratio of 23.52%
Current Ratio2.43
Quick Ratio2.09
Debt to Market Cap0.07
Net Debt to EBITDA-1.83
Interest Coverage Ratio-2.15
Taxes
In the past 12 months, Mesoblast Limited has paid 626.46K in taxes.
Income Tax626.46K
Effective Tax Rate-0.01
Enterprise Valuation
Mesoblast Limited EV to EBITDA ratio is -42.08, with an EV/FCF ratio of -41.04.
EV to Sales14.94
EV to EBITDA-42.08
EV to Free Cash Flow-41.04
EV to Operating Cash Flow-41.89
Balance Sheet
Mesoblast Limited has $129.57M in cash and marketable securities with $135.14M in debt, giving a net cash position of -$5.57M billion.
Cash & Marketable Securities$129.57M
Total Debt$135.14M
Net Cash-$5.57M
Net Cash Per Share>-$0.01
Tangible Book Value Per Share<$0.01
Margins
Gross margin is -53.34%, with operating margin of -42.64%, and net profit margin of -47.82%.
Gross Margin-53.34%
Operating Margin-42.64%
Pretax Margin-47.31%
Net Profit Margin-47.82%
EBITDA Margin-35.50%
EBIT Margin-42.64%
Analyst Forecast
The average price target for Mesoblast Limited is $2.62, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$2.62
Price Target Upside37.85% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast599.21%
EPS Growth Forecast47.52%